Literature DB >> 30112668

Acquired drug-induced long QTc: new insights coming from a retrospective study.

Renato De Vecchis1, Carmelina Ariano2, Giuseppina Di Biase3, Michel Noutsias4.   

Abstract

INTRODUCTION: Several drug classes (antiarrhythmics, antimicrobials, antidepressants, phenothiazines, opiates, prokinetics of digestive tract, etc.) have been related to ventricular hyperkinetic arrhythmias such as torsade de pointes (TdP). TdPs are usually heralded by an abnormal prolongation of heart rate-corrected QT interval on the electrocardiogram, so-called drug-induced long heart rate-corrected QT (diLQTc). We do not know to what extent the drug-induced QTc prolongation is able to predict malignant arrhythmias. Thus, we have retrospectively examined the clinical history of patients with diLQTc.
METHODS: The case record, concerning the period January 2008-December 2017, was collected from two hospitals. diLQTc was defined as drug-induced heart rate-corrected QT of ≥ 450 ms or ≥ 470 ms, respectively in male or female patients. The primary purpose was to verify whether in diLQTc patients the length of this electrocardiographic segment was associated with the risk of symptoms or events (TdP, ventricular fibrillation).
RESULTS: Seventy-three validated cases of diLQTc were gathered. Among them, the QTc duration was not able to predict the occurrence of symptoms or events (odds ratio, 0.998; 95% CI, 0.984 to 1.013; p = 0.8821). Likewise, a diQTc lasting longer than 500 ms compared to diQTc comprised between 450 and 500 ms was not associated with an increased risk of arrhythmic events.
CONCLUSIONS: In our diLQTc patients, QTc duration did not predict occurrence of symptoms, or arrhythmic events. Thus, other determinants should be postulated to clarify why sometimes diQTc prolongation propitiates ventricular malignant arrhythmias whereas in other cases this arrhythmogenic effect is lacking.

Entities:  

Keywords:  Drug-induced long-QT syndrome; Prediction of cardiovascular events; QT corrected for heart rate; Torsade de pointes

Mesh:

Year:  2018        PMID: 30112668     DOI: 10.1007/s00228-018-2537-y

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  13 in total

1.  Effects of cisapride on corrected QT interval, heart rate, and rhythm in infants undergoing polysomnography.

Authors:  A Benatar; A Feenstra; T Decraene; Y Vandenplas
Journal:  Pediatrics       Date:  2000-12       Impact factor: 7.124

2.  Congenital deaf-mutism, functional heart disease with prolongation of the Q-T interval and sudden death.

Authors:  A JERVELL; F LANGE-NIELSEN
Journal:  Am Heart J       Date:  1957-07       Impact factor: 4.749

Review 3.  Drug-induced prolongation of the QT interval.

Authors:  Dan M Roden
Journal:  N Engl J Med       Date:  2004-03-04       Impact factor: 91.245

Review 4.  Congenital long QT syndrome: considerations for primary care physicians.

Authors:  Ethan Levine; Spencer Z Rosero; Adam S Budzikowski; Arthur J Moss; Wojciech Zareba; James P Daubert
Journal:  Cleve Clin J Med       Date:  2008-08       Impact factor: 2.321

Review 5.  Sudden cardiac death and preparticipation screening: the debate continues-in support of electrocardiogram-inclusive preparticipation screening.

Authors:  Irfan M Asif; Jonathan A Drezner
Journal:  Prog Cardiovasc Dis       Date:  2012 Mar-Apr       Impact factor: 8.194

Review 6.  Hopes and disappointments with antiarrhythmic drugs.

Authors:  A John Camm
Journal:  Int J Cardiol       Date:  2017-03-16       Impact factor: 4.164

7.  Torsades de pointes with a severely prolonged QT interval induced by an initial low dose sotalol intake.

Authors:  Kenan Yalta; Okan Turgut; Ahmet Yilmaz; M Birhan Yilmaz; Omer Kendirlioglu; Filiz Karadas
Journal:  Int J Cardiol       Date:  2006-11-27       Impact factor: 4.164

Review 8.  Congenital and acquired long QT syndrome. Current concepts and management.

Authors:  Chern-En Chiang
Journal:  Cardiol Rev       Date:  2004 Jul-Aug       Impact factor: 2.644

9.  Prevalence and Risk Factors of Prolonged Corrected QT Interval Among Children and Adolescents Treated With Antipsychotic Medications: A Long-Term Follow-Up in a Real-World Population.

Authors:  Inmaculada Palanca-Maresca; Belén Ruiz-Antorán; Gustavo Adolfo Centeno-Soto; Maria Azul Forti-Buratti; Ana Siles; Ana Usano; Cristina Avendaño-Solá
Journal:  J Clin Psychopharmacol       Date:  2017-02       Impact factor: 3.153

10.  Incidence and clinical features of the quinidine-associated long QT syndrome: implications for patient care.

Authors:  D M Roden; R L Woosley; R K Primm
Journal:  Am Heart J       Date:  1986-06       Impact factor: 4.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.